CN103361198B - 川芎消炎复合香皂 - Google Patents
川芎消炎复合香皂 Download PDFInfo
- Publication number
- CN103361198B CN103361198B CN201310193059.2A CN201310193059A CN103361198B CN 103361198 B CN103361198 B CN 103361198B CN 201310193059 A CN201310193059 A CN 201310193059A CN 103361198 B CN103361198 B CN 103361198B
- Authority
- CN
- China
- Prior art keywords
- ligusticum wallichii
- parts
- sodium
- soap
- perfumed soap
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000344 soap Substances 0.000 title claims abstract description 45
- 241000112528 Ligusticum striatum Species 0.000 title claims abstract description 19
- 206010061218 Inflammation Diseases 0.000 title abstract description 5
- 230000003467 diminishing effect Effects 0.000 title abstract 4
- 230000004054 inflammatory process Effects 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000002994 raw material Substances 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 claims abstract description 6
- 239000011734 sodium Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 239000002131 composite material Substances 0.000 claims description 9
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 8
- -1 hydroxyethyl diamine Chemical class 0.000 claims description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 239000003352 sequestering agent Substances 0.000 claims description 7
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 6
- PDIZYYQQWUOPPK-UHFFFAOYSA-N acetic acid;2-(methylamino)acetic acid Chemical compound CC(O)=O.CC(O)=O.CNCC(O)=O PDIZYYQQWUOPPK-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 claims description 6
- 229940092705 beclomethasone Drugs 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000003760 tallow Substances 0.000 claims description 6
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 6
- 235000019864 coconut oil Nutrition 0.000 claims description 5
- 239000003240 coconut oil Substances 0.000 claims description 5
- 239000006260 foam Substances 0.000 abstract description 4
- KJDVLQDNIBGVMR-UHFFFAOYSA-L disodium;3-[2-aminoethyl-[2-(2-carboxylatoethoxy)ethyl]amino]propanoate Chemical compound [Na+].[Na+].[O-]C(=O)CCN(CCN)CCOCCC([O-])=O KJDVLQDNIBGVMR-UHFFFAOYSA-L 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 abstract 1
- 229940079857 disodium cocoamphodipropionate Drugs 0.000 abstract 1
- 229940080279 sodium cocoate Drugs 0.000 abstract 1
- 229940045870 sodium palmitate Drugs 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 17
- 210000004369 blood Anatomy 0.000 description 17
- 239000003814 drug Substances 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004898 kneading Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000007493 shaping process Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 229940120146 EDTMP Drugs 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 230000000452 restraining effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OHOTVSOGTVKXEL-WJXVXWFNSA-K trisodium;(2s)-2-[bis(carboxylatomethyl)amino]propanoate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)[C@H](C)N(CC([O-])=O)CC([O-])=O OHOTVSOGTVKXEL-WJXVXWFNSA-K 0.000 description 2
- BPSYZMLXRKCSJY-UHFFFAOYSA-N 1,3,2-dioxaphosphepan-2-ium 2-oxide Chemical compound O=[P+]1OCCCCO1 BPSYZMLXRKCSJY-UHFFFAOYSA-N 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- QILXPCHTWXAUHE-UHFFFAOYSA-N [Na].NCCN Chemical compound [Na].NCCN QILXPCHTWXAUHE-UHFFFAOYSA-N 0.000 description 1
- OQRDSLOUOFIGSC-UHFFFAOYSA-N [Na].[Na].[Na].[Na].[Na].NCCNCCN Chemical compound [Na].[Na].[Na].[Na].[Na].NCCNCCN OQRDSLOUOFIGSC-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 description 1
- 238000006757 chemical reactions by type Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- RWIGWWBLTJLKMK-UHFFFAOYSA-N diethoxyphosphorylmethanol Chemical compound CCOP(=O)(CO)OCC RWIGWWBLTJLKMK-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HPEUEJRPDGMIMY-IFQPEPLCSA-N molybdopterin Chemical compound O([C@H]1N2)[C@H](COP(O)(O)=O)C(S)=C(S)[C@@H]1NC1=C2N=C(N)NC1=O HPEUEJRPDGMIMY-IFQPEPLCSA-N 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000011309 nasal bleeding Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 230000009919 sequestration Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- WHNXAQZPEBNFBC-UHFFFAOYSA-K trisodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(2-hydroxyethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].OCCN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O WHNXAQZPEBNFBC-UHFFFAOYSA-K 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Abstract
本发明公开了一种川芎消炎复合香皂，包括以下重量份的原料：川芎提取物0.05-0.15份，椰油酸钠15-25份，棕榈酸钠50-70份，椰油酰两性基二丙酸二钠3-5份，氢化牛脂基胺氧化物3-5份，水20份。本发明的川芎消炎复合香皂，泡沫细腻稳定，性能温和，对皮肤的刺激性低,特别添加川芎提取物后，更能够消炎杀菌。
Description
技术领域：
本发明涉及一种香皂，特别涉及一种川芎消炎复合香皂。
背景技术：
香皂（soap）是皮肤、毛发洗涤护理用品之一，是一种日用消费品。香皂是以脂肪酸钠和其他表面活性剂为主要原料，添加品质改良剂和外观改良剂，经过加工成型后制成的产品。
香皂是日常生活中必不可少的洗涤护理用品，以脂肪酸钠和其他表面活性剂为主要原料，添加品质改良剂和外观改良剂，经过加工成型后制成的产品。香皂的功能是清洁洗涤，用在皮肤上面当然是清除泥土污垢、皮肤分泌物、排泄物、化学物质或细菌等等，在讲求美容效果的今日，清除皮肤表面之化妆品、保养品或药物也是其主要的用途之一。
在现有技术中，香皂比较多见地是脂肪酸钠盐为皂基的块状皂，虽然具有较好的清洗力、起泡性及易冲洗性，但是不耐硬水，洗涤时会产生水垢，形成钙镁皂，脱脂力强，人体长期使用偏碱性的皂会令皮肤感到干涩，有刺激感。
川芎，原名芎藭。一种中药植物，常用于活血行气，祛风止痛，主要栽培于四川、云南、贵州、广西、湖北等地。川芎辛温香燥，走而不守，既能行散，上行可达巅顶；又入血分，下行可达血海。活血祛瘀作用广泛，适宜瘀血阻滞各种病症；祛风止痛，效用甚佳，可治头风头痛、风湿痹痛等症。昔人谓川芎为血中之气药，殆言其寓辛散、解郁、通达、止痛等功能。本品辛温升散，凡阴虚阳亢及肝阳上亢者不宜应用；月经过多、孕妇亦忌用。
抗菌作用等体外试验，川芎对大肠、痢疾（宋内氏）、变形、绿脓、伤寒、副伤寒杆菌及霍乱弧菌等有抑制作用。川芎水浸剂（1:3）在试管内对某些致病性皮肤真菌也有抑制作用。
《本经》：主中风入脑头痛，寒痹，筋挛缓急，金创，妇人血闭无子。
《别录》：除脑中冷动，面上游风去来，目泪出，多涕唾，忽忽如醉，诸寒冷气，心腹坚痛，中恶，卒急肿痛，胁风痛，温中内寒。陶弘景：齿根出血者，含之多瘥。
《药性论》：治腰脚软弱，半身不遂，主胞衣不出，治腹内冷痛。
《日华子本草》：治一切风，一切气，一切劳损，一切血，补五劳，壮筋骨，调众脉，破症结宿血，养新血，长肉，鼻洪，吐血及溺血，痔瘘，脑痈发背，瘰疬瘿赘，疮疥，及排脓消瘀血。
《医学启源》：补血，治血虚头痛。王好古：搜肝气，补肝血，润肝燥，补风虚。
《纲目》：燥湿，止泻痢，行气开郁。芎藭，血中气药也，肝苦急以辛补之，故血虚者宜之；辛以散之，故气郁者宜之。
《左传》言麦麴、鞠穷御湿，治河鱼腹疾。予治湿泻，每加二味，其应如响。血痢已通而痛不止者，乃阴亏气郁，药中加芎为佐，气行血调，其病立止。
《本草衍义》：芎藭，今人所用最多，头面风不可阙也，然须以他药佐之。
发明内容：
针对现有技术存在的上述不足，本发明所要解决的技术问题是提供一种川芎消炎复合香皂。
本发明的技术问题，是通过下述技术方案得以实现的：
一种川芎消炎复合香皂，包括以下重量份的原料：川芎提取物0.05-0.15份，椰油酸钠15-25份，棕榈酸钠50-70份，椰油酰两性基二丙酸二钠3-5份，氢化牛脂基胺氧化物3-5份，水20份。
优选地，一种川芎消炎复合香皂，包括以下重量份的原料：川芎提取物0.05-0.15份，螯合剂0.5-1.5份，椰油酰两性基二丙酸二钠3-5份，氢化牛脂基胺氧化物3-5份，椰油酸钠15-25份，棕榈酸钠50-70份，水20份。
所述螯合剂为乙二胺四乙酸二钠盐、乙二胺四乙酸四钠盐、乙二胺四亚甲基膦酸、羟甲基膦酸二乙酯、二乙烯三胺五亚甲基膦酸钠、己二胺四甲叉膦酸、二己烯三胺五甲叉膦酸、二亚乙基三胺五亚甲基膦酸七钠盐、乙二胺四(亚甲基膦酸)六钠盐、乙二胺四亚甲基膦酸钠、甲基甘氨酸二乙酸三钠盐和羟乙基二胺四乙酸三钠盐中的一种或其混合物。
最优地，所述螯合剂，由下述组分按重量份组成：甲基甘氨酸二乙酸三钠盐40-60份和羟乙基二胺四乙酸三钠盐40-60份。
下面，对本发明所涉及的部分原料做出简单说明：
本发明的川芎提取物可以通过市售而得，如深圳波顿香料有限公司生产的川芎提取物。该川芎提取物也可以采用下述方法制备而得：把川芎粉碎后，加6-10重量倍的去离子水，浸泡1-3小时，超声波提取10-15分钟，过滤，离心，弃去沉淀将上清液浓缩，制得川芎提取物，控制川芎提取物密度在1.05g/cm3左右。
椰油酰两性基二丙酸二钠，CAS登录号：68411-57-4。
氢化牛脂基胺氧化物，CAS登录号:61788-94-1。
所述甲基甘氨酸二乙酸三钠盐，CAS登录号:170492-24-7，其英文名:L-Alanine，N，N-bis(carboxymethyl)-，sodium salt(1:3)。它较之常用的螯合剂EDTA、NTA有更好的生物降解性，在较宽的PH范围和高温下，比较稳定，具有较高的钙螯合能力，且对无机沉淀物有较高的溶解性能，对重金属有较好的螯合能力。在本发明中选用BASF公司生产的
所述羟乙基二胺四乙酸三钠盐，CAS登录号:207386-87-6，其英文名:Glycine，N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)-，trisodiumsalt，hydrate(9CI)。
此外，在本发明中，还可以添加普通香皂中常用的其它功能性成分，例如：抗菌剂、颜料、香精、抗氧剂、钛白粉等，以分别实现相应功能。如在本发明的配方基础上添加0.2-0.8重量份的抗菌剂、0.05-0.20重量份的抗氧化剂、0.02-0.2重量份的防腐剂，0.02-2重量份的钛白粉、0.001-0.05重量份的荧光增白剂或0.2-1.2重量份的香精。
本发明的川芎消炎复合香皂可采用本行业普通香皂的一般制皂步骤进行制备，如：
（a）捏和拌料：将上述组分的各种原料按比例称取加入到常规制皂用的捏和机中，捏和搅拌混合均匀。
（b）研磨：将捏和搅拌混合均匀后的物料，进入研磨机中，进行皂体研磨。
（c）真空压条：将研磨后的皂体，进入真空压条机，进行真空压条。
（d）打印：压条机压出的长条皂体直接进入打印机打印，得到成型的皂体。
本发明的川芎消炎复合香皂，泡沫细腻稳定，性能温和，对皮肤的刺激性低,特别添加川芎提取物后，更能够消炎杀菌。
具体实施方式：
下面实施例是对本发明的进一步说明，而不是限制本发明的范围。在本发明中，如无特别说明，各原料均以有效物含量为100%计。
实施例1
按表1对应的实施例1数据称取各原料。
（a）捏和拌料：将各种原料加入到皂用捏和机中，捏和搅拌混合均匀。
（b）研磨：将捏和搅拌混合均匀后的物料，进入研磨机中，进行皂体研磨。
（c）真空压条：将研磨后的皂体，进入真空压条机，进行真空压条。
（d）打印：压条机压出的长条皂体直接进入打印机打印，得到成型的皂体。
实施例2
按表1对应的实施例2数据称取各原料。按实施例1的方法制备香皂。
实施例3
按表1对应的实施例3数据称取各原料。按实施例1的方法制备香皂。
实施例4
按表1对应的实施例4数据称取各原料。按实施例1的方法制备香皂。
对比例1
按表1对应的对比例1数据称取各原料。按实施例1的方法制备香皂。
表1：香皂配方表 单位：公斤
| 实施例1 | 实施例2 | 实施例3 | 实施例4 | 对比例1 |
| 川芎提取物 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| 椰油酸钠 | 20 | 20 | 20 | 20 | 20 |
| 棕榈酸钠 | 60 | 60 | 60 | 60 | 60 |
| 椰油酰两性基二丙酸二钠 | 4 | 4 | 4 | 4 | / |
| 氢化牛脂基胺氧化物 | 4 | 4 | 4 | 4 | / |
| α-月桂基烷基甜菜碱 | / | / | / | / | 8 |
| 甲基甘氨酸二乙酸三钠盐 | / | 1 | / | 0.5 | / |
| 羟乙基二胺四乙酸三钠盐 | / | / | 1 | 0.5 | / |
| 水 | 20 | 20 | 20 | 20 | 20 |
测试例1：
实验用皂液浓度为5wt%，用量为0.3ml时，由HET VAM测试测定皮肤反应分级（相对刺激值分级），强烈刺激＞2.0，刺激1.2-2.0，中等刺激0.8-1.2，轻微刺激0.0-0.8。
使用罗氏泡沫仪进行泡沫性能测试，皂液浓度为2.5wt%，分别测试0分钟和5分钟的泡沫高度。
表2：测试数据表
结合表2的实验测试数据，本发明首创性地选用椰油酰两性基二丙酸二钠和氢化牛脂基胺氧化物复配皂基型阴离子表面活性剂椰油酸钠和棕榈酸钠，能够有效降低香皂的刺激性；首创性地选用螯合剂甲基甘氨酸二乙酸三钠盐和羟乙基二胺四乙酸三钠盐的复配添加，进一步能够提升香皂的发泡力和稳泡性。上述区别技术特征在现有技术中并未有过公开，也并非公知常识。
Claims (1)
1.一种川芎消炎复合香皂，其特征在于，包括以下重量份的原料：川芎提取物0.05-0.15份，螯合剂0.5-1.5份，椰油酰两性基二丙酸二钠3-5份，氢化牛脂基胺氧化物3-5份，椰油酸钠15-25份，棕榈酸钠50-70份，水20份，所述螯合剂，由下述组分按重量份组成：甲基甘氨酸二乙酸三钠盐40-60份和羟乙基二胺四乙酸三钠盐40-60份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310193059.2A CN103361198B (zh) | 2013-05-22 | 2013-05-22 | 川芎消炎复合香皂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310193059.2A CN103361198B (zh) | 2013-05-22 | 2013-05-22 | 川芎消炎复合香皂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103361198A CN103361198A (zh) | 2013-10-23 |
| CN103361198B true CN103361198B (zh) | 2015-01-07 |
Family
ID=49363468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310193059.2A Active CN103361198B (zh) | 2013-05-22 | 2013-05-22 | 川芎消炎复合香皂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103361198B (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1286723A (zh) * | 1997-10-23 | 2001-03-07 | 宝洁公司 | 含多取代蛋白酶变体的清洗组合物 |
| CN1670153A (zh) * | 2005-04-16 | 2005-09-21 | 王浩贵 | 川芎洗涤制品 |
| CN101357109A (zh) * | 2006-12-18 | 2009-02-04 | 程宇镳 | 一种日化用品组合物 |
| CN101455783A (zh) * | 2008-12-05 | 2009-06-17 | 包头市红卫日用化工有限公司 | 风湿止痛皂及其制备方法 |
| CN102363740A (zh) * | 2010-12-10 | 2012-02-29 | 江南大学 | 低刺激性和高发泡性的香皂配方 |
| CN102391919A (zh) * | 2011-02-14 | 2012-03-28 | 许扬 | 一种祛痘、防止皮肤过敏的中药香皂 |
-
2013
- 2013-05-22 CN CN201310193059.2A patent/CN103361198B/zh active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1286723A (zh) * | 1997-10-23 | 2001-03-07 | 宝洁公司 | 含多取代蛋白酶变体的清洗组合物 |
| CN1670153A (zh) * | 2005-04-16 | 2005-09-21 | 王浩贵 | 川芎洗涤制品 |
| CN101357109A (zh) * | 2006-12-18 | 2009-02-04 | 程宇镳 | 一种日化用品组合物 |
| CN101455783A (zh) * | 2008-12-05 | 2009-06-17 | 包头市红卫日用化工有限公司 | 风湿止痛皂及其制备方法 |
| CN102363740A (zh) * | 2010-12-10 | 2012-02-29 | 江南大学 | 低刺激性和高发泡性的香皂配方 |
| CN102391919A (zh) * | 2011-02-14 | 2012-03-28 | 许扬 | 一种祛痘、防止皮肤过敏的中药香皂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103361198A (zh) | 2013-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101125893B1 (ko) | 한방 화장비누 조성물 | |
| CN102940585B (zh) | 以天然来源原料为主的健康洗发露 | |
| CN105476950B (zh) | 保湿泡沫洁面乳及其制备方法 | |
| CN103194340B (zh) | 黄柏抗菌复合香皂 | |
| CN107913228A (zh) | 含生姜的无硅油保健洗发水及其制备工艺 | |
| CN103194342B (zh) | 桔梗美白复合香皂 | |
| CN103666886B (zh) | 三七低刺激护肤香皂 | |
| CN103361198B (zh) | 川芎消炎复合香皂 | |
| CN103361211B (zh) | 薄荷清凉复合香皂 | |
| CN103361209B (zh) | 蛇床子消炎复合香皂 | |
| CN103666885B (zh) | 红景天低刺激护肤香皂 | |
| CN105349282A (zh) | 一种多功能天然洗护液 | |
| CN103361213B (zh) | 天冬美白复合香皂 | |
| CN103666884B (zh) | 地榆抗菌复合香皂 | |
| CN103194341B (zh) | 黄芩低刺激护肤香皂 | |
| CN105902437A (zh) | 具有美容效果的洁面盐及制备方法 | |
| CN103361210B (zh) | 地黄抑油复合香皂 | |
| CN103361199B (zh) | 泽泻除体臭复合香皂 | |
| CN103666888B (zh) | 蒲公英低刺激护肤香皂 | |
| CN103695215B (zh) | 甘草低刺激护肤香皂 | |
| CN105687049A (zh) | 可有效去除面部暗疮的洗浴盐及制备方法 | |
| CN103666887B (zh) | 芦荟低刺激护肤香皂 | |
| CN105456134A (zh) | 具有保健功效的洗发盐及制备方法 | |
| CN106580753A (zh) | 一种肉桂沐浴露及其制备方法 | |
| CN107929201A (zh) | 一种防脱发的洗发液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Ren Yulong Inventor after: Li Xiaolei Inventor after: Ying Shi Inventor before: Huang Meirong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG MEIRONG TO: REN YULONG LI XIAOLEI YING SHI |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181217 Address after: 201111 E2128 first, 5500 Yuanjiang Road, Minhang District, Shanghai. Patentee after: Shanghai Yanzi Chemical Technology Co., Ltd. Address before: 201604 219, room 2, Lane 1000, Tower Road, Shek Hu Town, Songjiang District, Shanghai Patentee before: Shanghai Bafang Fine Chemical Engineering Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190920 Address after: 233010 Incubation Workshop, 414 Changle Road, Yuhui District, Bengbu City, Anhui Province Patentee after: Bengbu Xingshi Intellectual Property Operations Co., Ltd. Address before: 201111 Shanghai city Minhang District Yuanjiang Road No. 5500 building first room E2128 Patentee before: Shanghai Yanzi Chemical Technology Co., Ltd. |